国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant African horse sickness virus 6 Core protein VP7 (S7) CSB-YP526671AYC
CSB-EP526671AYC
CSB-BP526671AYC
CSB-MP526671AYC
CSB-EP526671AYC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Diatraea saccharalis densovirus Non-capsid protein NS-1 (NS1), partial CSB-YP526672DKB
CSB-EP526672DKB
CSB-BP526672DKB
CSB-MP526672DKB
CSB-EP526672DKB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Grapevine leafroll-associated virus 3 Movement protein p5 (ORF3), partial CSB-YP526673GHC
CSB-EP526673GHC
CSB-BP526673GHC
CSB-MP526673GHC
CSB-EP526673GHC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Grapevine leafroll-associated virus 3 Protein P7 (ORF12), partial CSB-YP526674GHC1
CSB-EP526674GHC1
CSB-BP526674GHC1
CSB-MP526674GHC1
CSB-EP526674GHC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zaire ebolavirus Nucleoprotein (NP), partial CSB-YP526675ZAT
CSB-EP526675ZAT
CSB-BP526675ZAT
CSB-MP526675ZAT
CSB-EP526675ZAT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cowpox virus Kelch repeat and BTB domain-containing protein 1 (KBTB1), partial CSB-YP526676DXL
CSB-EP526676DXL
CSB-BP526676DXL
CSB-MP526676DXL
CSB-EP526676DXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Fowlpox virus Scaffold protein D13 ortholog (FPV050, fp9.050), partial CSB-YP526677FEY
CSB-EP526677FEY
CSB-BP526677FEY
CSB-MP526677FEY
CSB-EP526677FEY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cowpox virus Soluble TNF receptor II (CRMB1) CSB-YP526678DXL
CSB-EP526678DXL
CSB-BP526678DXL
CSB-MP526678DXL
CSB-EP526678DXL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rana pipiens Guanylyl cyclase inhibitory protein (GCIP) CSB-YP526679RJN
CSB-EP526679RJN
CSB-BP526679RJN
CSB-MP526679RJN
CSB-EP526679RJN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Gamma-tubulin complex component 3 homolog (tubgcp3), partial CSB-YP526680XBE
CSB-EP526680XBE
CSB-BP526680XBE
CSB-MP526680XBE
CSB-EP526680XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Neurotrophin-7 (ntf7) CSB-YP526681DIL
CSB-EP526681DIL
CSB-BP526681DIL
CSB-MP526681DIL
CSB-EP526681DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Naja sputatrix Cytotoxin 5a CSB-YP526682NFH
CSB-EP526682NFH
CSB-BP526682NFH
CSB-MP526682NFH
CSB-EP526682NFH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis Insulin-like growth factor 2 mRNA-binding protein 3-A (igf2bp3-a), partial CSB-YP526683XBE
CSB-EP526683XBE
CSB-BP526683XBE
CSB-MP526683XBE
CSB-EP526683XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Catalase-peroxidase (katG), partial CSB-YP526684HTM
CSB-EP526684HTM
CSB-BP526684HTM
CSB-MP526684HTM
CSB-EP526684HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Putative antitoxin PH1062.1 (PH1062.1) CSB-YP526685FHX
CSB-EP526685FHX
CSB-BP526685FHX
CSB-MP526685FHX
CSB-EP526685FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 30S ribosomal protein S13P (rps13p) CSB-YP526686FHX
CSB-EP526686FHX
CSB-BP526686FHX
CSB-MP526686FHX
CSB-EP526686FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tungsten-containing formylmethanofuran dehydrogenase 2 subunit C (fwdC) CSB-YP526687MRQ
CSB-EP526687MRQ
CSB-BP526687MRQ
CSB-MP526687MRQ
CSB-EP526687MRQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 50S ribosomal protein L29P (rpl29p) CSB-YP526688FHX
CSB-EP526688FHX
CSB-BP526688FHX
CSB-MP526688FHX
CSB-EP526688FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii UPF0147 protein PH1921.2 (PH1921.2) CSB-YP526689FHX
CSB-EP526689FHX
CSB-BP526689FHX
CSB-MP526689FHX
CSB-EP526689FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Casein kinase I homolog 3 (cki3) CSB-YP526690SXV
CSB-EP526690SXV
CSB-BP526690SXV
CSB-MP526690SXV
CSB-EP526690SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>